The biopharmaceutical industry has advanced and grown over the last number of years. With improvements in manufacturing through alliances and collaborations, global development is now truly achievable. With increasing focus on scale-up and reduction in cost and time, this brings increased manufacturing flexibility and decreased timelines.
The ever growing challenges of regulation, feasibility and clinical development are all still very much at the forefront of the biopharmaceutical industry. bioLOGIC Europe 2006 will cover the key issues facing the industry.
|
